A. Putri, I. Rinaldi, M. Louisa, and S. Koesnoe, “The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients”, Acta Med Indones, vol. 51, no. 4, p. 348, Feb. 2020.